Literature DB >> 3348103

Chronic atrial fibrillation. Long-term results of direct current conversion.

T Lundström1, L Rydén.   

Abstract

One hundred consecutive patients admitted in 1980-82 for direct current conversion of chronic atrial fibrillation (AF) were followed. The first attempt to convert was made without the institution of class I antiarrhythmics. If AF relapsed, patients were selected for further conversions, in connection with which quinidine or disopyramide treatment was instituted. The proportion of patients maintaining sinus rhythm (SR) one and two years after the first conversion was 23% and 16%, after the second conversion 40% and 33% and after any number of conversions [1-12] 54% and 41%. Fifty-three per cent of the patients were symptomless before at least one conversion. Of the patients maintaining SR two years after conversion, 46% did not receive antiarrhythmic therapy. More than two conversions should be exceptional since symptoms of AF are often absent and the additional effect of further conversions is minor. A first attempt to convert without antiarrhythmics identifies a substantial proportion of patients maintaining SR without any prophylactic antiarrhythmic therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348103

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  26 in total

Review 1.  In-hospital approach to newly recognized atrial fibrillation.

Authors:  C D Kimmelstiel; M Homoud; C A Clyne; M Estes III
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

Review 2.  Chemical transmitter systems in the brain.

Authors:  C C Shute
Journal:  Mod Trends Neurol       Date:  1975

Review 3.  Dofetilide: a review of its use in atrial fibrillation and atrial flutter.

Authors:  K J McClellan; A Markham
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

4.  A short course of oral amiodarone improves sinus rhythm maintenance post-cardioversion for atrial fibrillation.

Authors:  C Boos; J Ritzema; R S More
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 5.  Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation.

Authors:  R H Foster; M I Wilde; A Markham
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

6.  New deal for old hearts.

Authors:  O M Jolobe
Journal:  BMJ       Date:  1991-08-10

7.  Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation.

Authors:  K E Paravolidakis; T M Kolettis; G N Theodorakis; I A Paraskevaidis; T S Apostolou; D T Kremastinos
Journal:  J Interv Card Electrophysiol       Date:  1998-09       Impact factor: 1.900

8.  Higher energy monophasic DC cardioversion for persistent atrial fibrillation: is it time to start at 360 joules?

Authors:  C Boos; M D Thomas; A Jones; E Clarke; G Wilbourne; R S More
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 9.  Novel approaches for the surgical treatment of atrial fibrillation: time for a guideline revision?

Authors:  Carlo Nicola De Cecco; Vitaliano Buffa; Vincenzo David; Stefano Fedeli
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

Review 10.  Evolving concepts in the treatment of atrial fibrillation.

Authors:  Parimal B Maniar; Jonathan S Steinberg
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.